-
1
-
-
0034721761
-
Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation
-
Draganov DI, Stetson PL, Watson CE, Billecke SS & La Du BN. Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation. Journal of Biological Chemistry 2000 275 33435-33442.
-
(2000)
Journal of Biological Chemistry
, vol.275
, pp. 33435-33442
-
-
Draganov, D.I.1
Stetson, P.L.2
Watson, C.E.3
Billecke, S.S.4
La Du, B.N.5
-
2
-
-
2642570389
-
Paraoxonase, a cardioprotective enzyme: Continuing issues
-
Getz GS & Reardon CA. Paraoxonase, a cardioprotective enzyme: continuing issues. Current Opinion in Lipidology 2004 15 261-267.
-
(2004)
Current Opinion in Lipidology
, vol.15
, pp. 261-267
-
-
Getz, G.S.1
Reardon, C.A.2
-
3
-
-
4043096346
-
Paraoxonase 1 activity, concentration and genotype in cardiovascular diseases
-
Mackness M, Durrington PN & Mackness B. Paraoxonase 1 activity, concentration and genotype in cardiovascular diseases. Current Opinion in Lipidology 2004 15 399-404.
-
(2004)
Current Opinion in Lipidology
, vol.15
, pp. 399-404
-
-
Mackness, M.1
Durrington, P.N.2
Mackness, B.3
-
4
-
-
0038706687
-
Expert panel on the detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. II Rationale for intervention
-
Third Report of the National Cholesterol Education Program NCEP
-
Third Report of the National Cholesterol Education Program (NCEP). Expert panel on the detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. II Rationale for intervention. Circulation 2002 106 3188-3190.
-
(2002)
Circulation
, vol.106
, pp. 3188-3190
-
-
-
6
-
-
52949142682
-
Nonalcoholic fatty liver disease: A manifestation of the metabolic syndrome
-
Kim CH & Younossi ZM. Nonalcoholic fatty liver disease: a manifestation of the metabolic syndrome. Cleveland Clinic Journal of Medicine 2008 75 721-728.
-
(2008)
Cleveland Clinic Journal of Medicine
, vol.75
, pp. 721-728
-
-
Kim, C.H.1
Younossi, Z.M.2
-
7
-
-
49649092062
-
Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease
-
Holvoet P. Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease. Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie 2008 70 193-219.
-
(2008)
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie
, vol.70
, pp. 193-219
-
-
Holvoet, P.1
-
8
-
-
0346023040
-
A novel automated method to measure total antioxidant response against potent free radical reactions
-
Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clinical Biochemistry 2004 37 112-119.
-
(2004)
Clinical Biochemistry
, vol.37
, pp. 112-119
-
-
Erel, O.1
-
9
-
-
29144527533
-
A new automated colorimetric method for measuring total oxidant status
-
Erel O. A new automated colorimetric method for measuring total oxidant status. Clinical Biochemistry 2005 38 1103-1111.
-
(2005)
Clinical Biochemistry
, vol.38
, pp. 1103-1111
-
-
Erel, O.1
-
10
-
-
27844562708
-
Increased oxidative stress associated with the severity of the liver disease in various forms of hepatitis B virus infection
-
Bolukbas C, Bolukbas FF, Horoz M, Aslan M, Celik H & Erel O. Increased oxidative stress associated with the severity of the liver disease in various forms of hepatitis B virus infection. BMC Infectious Diseases 2005 5 95.
-
(2005)
BMC Infectious Diseases
, vol.5
, pp. 95
-
-
Bolukbas, C.1
Bolukbas, F.F.2
Horoz, M.3
Aslan, M.4
Celik, H.5
Erel, O.6
-
12
-
-
84943995885
-
-
Haagen L & Brock A. A new automated method for phenotyping arylesterase (E.C.3.1.1.2.) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate. European Journal of Clinical Chemistry and Clinical Biochemistry 1992 30 391-395.
-
Haagen L & Brock A. A new automated method for phenotyping arylesterase (E.C.3.1.1.2.) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate. European Journal of Clinical Chemistry and Clinical Biochemistry 1992 30 391-395.
-
-
-
-
13
-
-
0021813187
-
Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
-
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419.
-
(1985)
Diabetologia
, vol.28
, pp. 412-419
-
-
Matthews, D.R.1
Hosker, J.P.2
Rudenski, A.S.3
Naylor, B.A.4
Treacher, D.F.5
Turner, R.C.6
-
14
-
-
33745995176
-
Insulin sensitivity indices: A proposal of cut-off points for simple identification of insulin-resistant subjects
-
Radikova Z, Koska J, Huckova M, Ksinatova L, Imrich R, Vigas M, Trnovec T, Langer P, Sebokova E & Klimes I. Insulin sensitivity indices: a proposal of cut-off points for simple identification of insulin-resistant subjects. Experimental and Clinical Endocrinology and Diabetes 2006 114 249-256.
-
(2006)
Experimental and Clinical Endocrinology and Diabetes
, vol.114
, pp. 249-256
-
-
Radikova, Z.1
Koska, J.2
Huckova, M.3
Ksinatova, L.4
Imrich, R.5
Vigas, M.6
Trnovec, T.7
Langer, P.8
Sebokova, E.9
Klimes, I.10
-
15
-
-
6344267152
-
Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity
-
Hansel B, Giral P, Nobecourt E, Chantepie S, Bruckert E, Chapman MJ & Kontush A. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. Journal of Clinical Endocrinology and Metabolism 2004 89 4963-4971.
-
(2004)
Journal of Clinical Endocrinology and Metabolism
, vol.89
, pp. 4963-4971
-
-
Hansel, B.1
Giral, P.2
Nobecourt, E.3
Chantepie, S.4
Bruckert, E.5
Chapman, M.J.6
Kontush, A.7
-
16
-
-
2342446885
-
-
Eschwege E. The dysmetabolic syndrome, insulin resistance and increased cardiovascular (CV) morbidity and mortality in type 2 diabetes: aetiological factors in the development of CV complications. Diabetes & Metabolism 2003 29 6S19-6S27.
-
Eschwege E. The dysmetabolic syndrome, insulin resistance and increased cardiovascular (CV) morbidity and mortality in type 2 diabetes: aetiological factors in the development of CV complications. Diabetes & Metabolism 2003 29 6S19-6S27.
-
-
-
-
17
-
-
0034939115
-
The role of oxidative stress in the onset and progression of diabetes and its complications: A summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society
-
Rosen P, Nawroth PP, King G, Moller W, Tritschler HJ & Packer L. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes/Metabolism Research and Reviews 2001 17 189-212.
-
(2001)
Diabetes/Metabolism Research and Reviews
, vol.17
, pp. 189-212
-
-
Rosen, P.1
Nawroth, P.P.2
King, G.3
Moller, W.4
Tritschler, H.J.5
Packer, L.6
-
18
-
-
0344011135
-
Antioxidant paraoxonase 1 activity in the metabolic syndrome
-
Senti M, Tomas M, Fito M, Weinbrenner T, Covas MI, Sala J, Masia R & Marrugat J. Antioxidant paraoxonase 1 activity in the metabolic syndrome. Journal of Clinical Endocrinology and Metabolism 2003 88 5422-5426.
-
(2003)
Journal of Clinical Endocrinology and Metabolism
, vol.88
, pp. 5422-5426
-
-
Senti, M.1
Tomas, M.2
Fito, M.3
Weinbrenner, T.4
Covas, M.I.5
Sala, J.6
Masia, R.7
Marrugat, J.8
-
19
-
-
67349091737
-
Oxidative stress and metabolic syndrome
-
Roberts CK & Sindhu KK. Oxidative stress and metabolic syndrome. Life Sciences 2009 84 705-712.
-
(2009)
Life Sciences
, vol.84
, pp. 705-712
-
-
Roberts, C.K.1
Sindhu, K.K.2
-
20
-
-
35048877043
-
Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity
-
Vincent HK, Innes KE & Vincent KR. Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity. Diabetes, Obesity and Metabolism 2007 9 813-839.
-
(2007)
Diabetes, Obesity and Metabolism
, vol.9
, pp. 813-839
-
-
Vincent, H.K.1
Innes, K.E.2
Vincent, K.R.3
-
21
-
-
39349091237
-
The evaluation of serum cystatin C, malondialdehyde, and total antioxidant status in patients with metabolic syndrome
-
Demircan N, Gurel A, Armutcu F, Unalalacak M, Aktunc E & Atmaca H. The evaluation of serum cystatin C, malondialdehyde, and total antioxidant status in patients with metabolic syndrome. Medical Science Monitor 2008 14 97-101.
-
(2008)
Medical Science Monitor
, vol.14
, pp. 97-101
-
-
Demircan, N.1
Gurel, A.2
Armutcu, F.3
Unalalacak, M.4
Aktunc, E.5
Atmaca, H.6
-
22
-
-
0030048496
-
Oxidative stress and diabetic vascular complications
-
Giugliano D, Ceriello A & Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996 19 257-267.
-
(1996)
Diabetes Care
, vol.19
, pp. 257-267
-
-
Giugliano, D.1
Ceriello, A.2
Paolisso, G.3
-
23
-
-
11144225245
-
Oxidative stress and vascular disease
-
Madamanchi NR, Vendrov A & Runge MS. Oxidative stress and vascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 29-38.
-
(2005)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.25
, pp. 29-38
-
-
Madamanchi, N.R.1
Vendrov, A.2
Runge, M.S.3
-
24
-
-
52049099354
-
Role of oxidative stress and nitric oxide in atherothrombosis
-
Lubos E, Handy DE & Loscalzo J. Role of oxidative stress and nitric oxide in atherothrombosis. Frontiers in Bioscience 2008 13 5323-5344.
-
(2008)
Frontiers in Bioscience
, vol.13
, pp. 5323-5344
-
-
Lubos, E.1
Handy, D.E.2
Loscalzo, J.3
-
25
-
-
10244255151
-
Association between serum paraoxonase activity and oxidative stress in acute coronary syndromes
-
Kabaroglu C, Mutaf I, Boydak B, Ozmen D, Habif S, Erdener D, Parildar Z & Bayindir O. Association between serum paraoxonase activity and oxidative stress in acute coronary syndromes. Acta Cardiologica 2004 59 606-611.
-
(2004)
Acta Cardiologica
, vol.59
, pp. 606-611
-
-
Kabaroglu, C.1
Mutaf, I.2
Boydak, B.3
Ozmen, D.4
Habif, S.5
Erdener, D.6
Parildar, Z.7
Bayindir, O.8
-
26
-
-
15944392472
-
Paraoxonase activity in high-density lipoproteins: A comparison between healthy and obese females
-
Ferretti G, Bacchetti T, Moroni C, Savino S, Liuzzi A, Balzoa F & Bicchiega V. Paraoxonase activity in high-density lipoproteins: a comparison between healthy and obese females. Journal of Clinical Endocrinology and Metabolism 2005 90 1728-1733.
-
(2005)
Journal of Clinical Endocrinology and Metabolism
, vol.90
, pp. 1728-1733
-
-
Ferretti, G.1
Bacchetti, T.2
Moroni, C.3
Savino, S.4
Liuzzi, A.5
Balzoa, F.6
Bicchiega, V.7
-
27
-
-
33646945008
-
Ciprofibrate increases paraoxonase activity in patients with metabolic syndrome
-
Paragh G, Seres I, Harangi M, Erdei A, Audikovszky M, Debreczeni L, Kovacsay A, Illyes L & Pados G. Ciprofibrate increases paraoxonase activity in patients with metabolic syndrome. British Journal of Clinical Pharmacology 2006 61 694-701.
-
(2006)
British Journal of Clinical Pharmacology
, vol.61
, pp. 694-701
-
-
Paragh, G.1
Seres, I.2
Harangi, M.3
Erdei, A.4
Audikovszky, M.5
Debreczeni, L.6
Kovacsay, A.7
Illyes, L.8
Pados, G.9
-
28
-
-
34047262851
-
Orlistat increases serum paraoxonase activity in obese patients
-
Audikovszky M, Pados G, Seres I, Harangi M, Fulop P, Katona E, Illyes L, Winkler G, Katona EM & Paragh G. Orlistat increases serum paraoxonase activity in obese patients. Nutrition, Metabolism, and Cardiovascular Diseases 2007 17 268-273.
-
(2007)
Nutrition, Metabolism, and Cardiovascular Diseases
, vol.17
, pp. 268-273
-
-
Audikovszky, M.1
Pados, G.2
Seres, I.3
Harangi, M.4
Fulop, P.5
Katona, E.6
Illyes, L.7
Winkler, G.8
Katona, E.M.9
Paragh, G.10
-
29
-
-
0034995225
-
Relationship of age-related myocardial infarction risk and Gln/Arg 192 variants of the human paraoxonase1 gene: The REGICOR study
-
Senti M, Tomas M, Vila J, Marrugat J, Elosua R, Sala J & Masia R. Relationship of age-related myocardial infarction risk and Gln/Arg 192 variants of the human paraoxonase1 gene: the REGICOR study. Atherosclerosis 2001 156 443-449.
-
(2001)
Atherosclerosis
, vol.156
, pp. 443-449
-
-
Senti, M.1
Tomas, M.2
Vila, J.3
Marrugat, J.4
Elosua, R.5
Sala, J.6
Masia, R.7
-
30
-
-
0031859456
-
-
Mackness B, Mackness MI, Arrol S, TurkieW, Julier K, Abuasha B, Miller JE, Boulton AJM & Durrington PN. Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus. Atherosclerosis 1998 139 341-349.
-
Mackness B, Mackness MI, Arrol S, TurkieW, Julier K, Abuasha B, Miller JE, Boulton AJM & Durrington PN. Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus. Atherosclerosis 1998 139 341-349.
-
-
-
-
31
-
-
0038616178
-
Interrelationship of smoking, paraoxonase activity and leisure-time physical activity: A population-based study
-
Senti M, Tomas M, Anglada R, Elosua R, Marrugat J, Covas MI & Fitoo M. Interrelationship of smoking, paraoxonase activity and leisure-time physical activity: a population-based study. European Journal of Internal Medicine 2003 14 178-184.
-
(2003)
European Journal of Internal Medicine
, vol.14
, pp. 178-184
-
-
Senti, M.1
Tomas, M.2
Anglada, R.3
Elosua, R.4
Marrugat, J.5
Covas, M.I.6
Fitoo, M.7
|